Viewing Study NCT05839951


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-26 @ 4:53 PM
Study NCT ID: NCT05839951
Status: COMPLETED
Last Update Posted: 2025-11-12
First Post: 2023-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module